Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients

Onal C., Ozyigit G., Cem G., Hurmuz P., Torun N., Tuncel M., ...Daha Fazla

RADIOTHERAPY AND ONCOLOGY, cilt.151, ss.222-227, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 151
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1016/j.radonc.2020.08.021
  • Dergi Adı: RADIOTHERAPY AND ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, EMBASE, Gender Studies Database, MEDLINE, DIALNET
  • Sayfa Sayıları: ss.222-227
  • Anahtar Kelimeler: Prostate cancer, Radiotherapy, Prostate-specific membrane antigen, Positron emission tomography, Treatment volume, RADICAL PROSTATECTOMY, RADIATION ONCOLOGY, PATTERNS, FAILURE, ADENOCARCINOMA, IRRADIATION, THERAPY, PET/CT
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Purpose: To evaluate the distribution of metastatic lymph nodes (LN) detected on Ga-68-PSMA-positron emission tomography/computed tomography (PET/CT) in treatment-naive prostate cancer (PC) patients and to analyze the LN coverage rates of the pelvic fields defined in the GETUG trial and RTOG guidelines and a pelvic field extending superiorly from the L4/L5 interspace.